Safety of erlotinib treatment in outpatients with previously treated non-small-cell lung cancer in Japan

被引：0
|
作者：
Hiroki Nagai
Shiro Tanaka
Miyuki Niimi
Nanae Seo
Takahiko Sasaki
Hiroshi Date
Michiaki Mishima
Hiroyasu Yasuda
Kazuhiro Yanagihara
机构：
[1] Outpatient Oncology Unit,Department of Respiratory Medicine, Graduate School of Medicine
[2] Kyoto University Hospital,Department of Clinical Trial Design and Management, Translational Research Center
[3] Kyoto University,Department of Respiratory Medicine
[4] Kyoto University Hospital,Department of Thoracic Surgery, Graduate School of Medicine
[5] Tohoku University School of Medicine,Department of Clinical Application
[6] Kyoto University,Department of Translational Clinical Oncology, Graduate School of Medicine
[7] Tohoku University Translational Research Center,undefined
[8] Kyoto University,undefined
来源：
International Journal of Clinical Oncology | 2011年 / 16卷
关键词：
Erlotinib; Epidermal growth factor receptor; Epidermal growth factor receptor–tyrosine kinase inhibitor; Adverse events; Non-small-cell lung cancer; Japanese outpatients;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Safety of erlotinib treatment in outpatients with previously treated non-small-cell lung cancer in Japan
    Nagai, Hiroki
    Tanaka, Shiro
    Niimi, Miyuki
    Seo, Nanae
    Sasaki, Takahiko
    Date, Hiroshi
    Mishima, Michiaki
    Yasuda, Hiroyasu
    Yanagihara, Kazuhiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (05) : 560 - 567
  • [2] Erlotinib in previously treated non-small-cell lung cancer
    Shepherd, FA
    Pereira, JR
    Ciuleanu, T
    Tan, EH
    Hirsh, V
    Thongprasert, S
    Campos, D
    Maoleekoonpiroj, S
    Smylie, M
    Martins, R
    van Kooten, M
    Dediu, M
    Findlay, B
    Tu, DS
    Johnston, D
    Bezjak, A
    Clark, G
    Santabárbara, P
    Seymour, L
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02): : 123 - 132
  • [3] Erlotinib in previously treated non small cell lung cancer
    Krause, M
    Baumann, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (01) : 55 - 57
  • [4] Erlotinib in the treatment of non-small-cell lung cancer
    Kyte, J.
    Wilson, P. C.
    Dangoor, A.
    LUNG CANCER, 2012, 75 : S6 - S7
  • [5] Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer
    Ricciardi, Serena
    Tomao, Silverio
    de Marinis, Filippo
    LUNG CANCER-TARGETS AND THERAPY, 2011, 2 : 1 - 9
  • [6] Efficacy and Safety of Erlotinib in Previously Treated Advanced Non-Small Cell Lung Cancer
    Karaca, Halit
    Geredeli, Caglayan
    Kaplan, M. Ali
    Demirci, Umut
    Alici, Suleyman
    Artac, Mehmet
    Isikdogan, Abdurrahman
    Benekli, Mustafa
    Balakan, Ozan
    Arpaci, Erkan
    Budakoglu, Burcin
    Uncu, Dogan
    Guler, Tunc
    Berk, Veil
    Ozkan, Metin
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2013, 23 (01): : 1 - 6
  • [7] Gefitinib or erlotinib in previously treated non-small-cell lung cancer patients: a cohort study in Taiwan
    Chang, Chia-Hao
    Lee, Chih-Hsin
    Ko, Jen-Chung
    Chang, Lih-Yu
    Lee, Ming-Chia
    Wang, Jann-Yuan
    Yu, Chong-Jen
    CANCER MEDICINE, 2017, 6 (07): : 1563 - 1572
  • [8] PEMETREXED IN PREVIOUSLY TREATED NON-SMALL-CELL LUNG CANCER
    Cho, E.
    Hong, J.
    Kim, Y. S.
    Sim, S. J.
    Park, S. H.
    Park, J.
    Lee, J. H.
    Shin, D. B.
    ANNALS OF ONCOLOGY, 2008, 19 : 120 - 120
  • [9] Docetaxel for previously treated non-small-cell lung cancer
    Fossella, FV
    ONCOLOGY-NEW YORK, 2002, 16 (06): : 45 - 51
  • [10] Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib
    Cataldo, Vince D.
    Gibbons, Don L.
    Perez-Soler, Roman
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (10): : 947 - 955
12345